The emergence of the SARS-CoV-2 variant JN.1 has sparked global concern due to its distinct genetic features and heightened infectivity. Carrying more than 30 spike protein mutations, including the ...

The JN.1 subvariant of SARS-CoV-2 emerged in late 2023 and rapidly became dominant globally. In the past 6 months, JN.1 has continued to evolve, giving rise to multiple sublineages with unique spike ...

SARS-CoV-2 infection is associated with a transient, nonsustained increase in new-onset type 1 diabetes risk among children and adults.

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The relentless evolution of SARS-CoV-2 variants remains a formidable challenge to global public health, thus prompting significant concern among health authorities due to emergent strains. One such ...

A landmark study shows that bat viruses closely related to SARS-CoV-1 and SARS-CoV-2 emerged far from outbreak sites, pointing to the wildlife trade, not natural bat movement, as the most plausible ...

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...